Mapletree North Asia Commercial Trust

Mapletree North Asia Commercial Trust (MNACT) is the first REIT that offers investors the opportunity to invest in high quality commercial properties situated in prime locations in China, Hong Kong SAR1, Japan and South Korea. MNACT is also the fourth REIT sponsored by Mapletree Investments Pte Ltd a leading real estate development, investment, capital and property management company headquartered in Singapore.

See below for the Latest MNACT News, Analysis, Profit Results, Share Price Information, and Commentary. 

MPACT's unitholder distributions suffer a 3.5% drop despite NPI stability

It attributed the decline to finance costs and high interest rates.

MPACT’s net property income climbs 1.7% YoY to $182.4m in 3Q23/24

The strong performance of the REIT’s Singapore portfolio contributed to the increase.

MPACT's net property income rises 2.2% QoQ to $183.2m in 2QFY23/24

The REIT likewise reported gains in its gross revenue and DPU.

MPACT’s net income jumps 44.9% YoY in H1 FY22/23

The “all-rounded” improvements in the trust’s Singapore properties drove the increase.

MNACT’s net profit rises by 4.1% YoY to $81.5m in Q1 FY22/23

The profit growth was largely driven by two factors.

REITs: Top 10 outperformers for first half of May

The normalisation in Singapore has bode well for REITs in the retail sector.

MNACT, MCT unveil '4R' post-merger strategy

The strategy includes changes in their divestment and acquisitions plans.

Net asset value for MCT units to increase to $1.81 after merger with MNACT 

The estimate is based on the unaudited  FY21/22 results of MNACT and MCT.

MNACT's net income inches up by 10.2% in FY21/22

The increase was attributed to three factors.

MCT-MNACT merger likely to push through with revised trust scheme: analysts

MCT has offered an all-cash option of $1.1949 per unit to MNACT unitholders.

Mapletree North Asia Commercial Trust revision a win for unitholders: OCBC

The change is the most viable for conservative holders, says OCBC Investment Research.